Evidence map›Paper›PMID 27410384›Full record

ArticlePloS one2016

The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania.

Katharine Kripke, Nicole Perales, Jackson Lija, Bennet Fimbo, Eric Mlanga, Hally Mahler, James McOllogi Juma, Emmanuel Baingana, Marya Plotkin, Deogratias Kakiziba and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Evidence Gaps in Economic Evaluations of HIV Interventions Targeting Young People: A Systematic Review.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Katharine KripkeHealth Policy Project, Avenir Health, Glastonbury, Connecticut, United States of America.
Nicole PeralesHealth Policy Project, Futures Group, Washington, District of Columbia, United States of America.
Jackson LijaTanzania National AIDS Control Program, Dar es Salaam, Tanzania.
Bennet FimboIndependent Consultant, Dar es Salaam, Tanzania.
Eric MlangaU. S. Agency for International Development, Dar es Salaam, Tanzania.
Hally MahlerJhpiego, Dar es Salaam, Tanzania.
James McOllogi JumaTanzania National AIDS Control Program, Dar es Salaam, Tanzania.
Emmanuel BainganaJoint United Nations Programme on HIV/AIDS, Dar es Salaam, Tanzania.
Marya PlotkinU. S. Agency for International Development, Dar es Salaam, Tanzania.
Deogratias KakizibaUnited States Department of Defense, Dar es Salaam, Tanzania.
Iris SeminiJoint United Nations Programme on HIV/AIDS, Dar es Salaam, Tanzania.
Delivette CastorOffice of the U.S. Global AIDS Coordinator, Washington, District of Columbia, United States of America.
Emmanuel NjeuhmeliU. S. Agency for International Development, Washington, District of Columbia, United States of America.ORCID http://orcid.org/0000-0001-5370-4827
AIDS United · USAvenir Health · USFutures Group (United States) · USUnited States Agency for International Development · USUnited States Department of Defense · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince its launch in 2010, the Tanzania National Voluntary Medical Male Circumcision (VMMC) Program has focused efforts on males ages 10-34 in 11 priority regions. Implementers have noted that over 70% of VMMC clients are between the ages of 10 and 19, raising questions about whether additional efforts would be required to recruit men age 20 and above. This analysis uses mathematical modeling to examine the economic and epidemiological consequences of scaling up VMMC among specific age groups and priority regions in Tanzania. METHODS AND

findingsAnalyses were conducted using the Decision Makers' Program Planning Tool Version 2.0 (DMPPT 2.0), a compartmental model implemented in Microsoft Excel 2010. The model was populated with population, mortality, and HIV incidence and prevalence projections from external sources, including outputs from Spectrum/AIDS Impact Module (AIM). A separate DMPPT 2.0 model was created for each of the 11 priority regions. Tanzania can achieve the most immediate impact on HIV incidence by circumcising males ages 20-34. This strategy would also require the fewest VMMCs for each HIV infection averted. Circumcising men ages 10-24 will have the greatest impact on HIV incidence over a 15-year period. The most cost-effective approach (lowest cost per HIV infection averted) targets men ages 15-34. The model shows the VMMC program is cost saving in all 11 priority regions. VMMC program cost-effectiveness varies across regions due to differences in projected HIV incidence, with the most cost-effective programs in Njombe and Iringa.

conclusionsThe DMPPT 2.0 results reinforce Tanzania's current VMMC strategy, providing newfound confidence in investing in circumcising adolescents. Tanzanian policy makers and program implementers will continue to focus scale-up of VMMC on men ages 10-34 years, seeking to maximize program impact and cost-effectiveness while acknowledging trends in demand among the younger and older age groups.

Indexed as

AdolescentAdultAge FactorsChildCircumcision, MaleCost-Benefit AnalysisHIV InfectionsHumansIncidenceMaleModels, StatisticalNational Health ProgramsPrevalenceTanzaniaVoluntary ProgramsYoung Adult

Identifiers

PMID27410384
PMCPMC4943708
OpenAlexW2471321415

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.